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Abstract
Classical scrapie is a naturally transmitted prion disease of sheep and goats. Contaminated environments may
contribute to the spread of disease and evidence from animal models has implicated urine, blood, saliva, placenta
and faeces as possible sources of the infection. Here we sought to determine whether sheep naturally infected
with classical scrapie shed prions in their faeces. We used serial protein misfolding cyclic amplification (sPMCA)
along with two extraction methods to examine faeces from sheep during both the clinical and preclinical phases
of the disease and showed amplification of PrP
Sc in 7 of 15 and 14 of 14 sheep respectively. However PrP
Sc was
not amplified from the faeces of 25 sheep not exposed to scrapie. These data represent the first demonstration of
prion shedding in faeces from a naturally infected host and thus a likely source of prion contamination in the
environment.
Introduction
Prion diseases, or transmissible spongiform encephalopa-
thies (TSEs), are fatal, neurological disorders that affect a
range of mammalian species. They include scrapie in
sheep, chronic wasting disease (CWD) in deer, bovine
spongiform encephalopathy (BSE) in cattle and Creutz-
feldt-Jakob disease (CJD) in humans. The “protein-only”
hypothesis is the widely accepted paradigm for disease
propagation and is based on the conversion of an appar-
ently benign host prion protein (PrP
C) into a pathological
isoform, PrP
Sc, which constitutes the infectious agent [1].
To date PrP
Sc is the only validated biochemical marker
for prion diseases. These disorders are characterised by
prolonged incubation periods before the onset of clinical
signs, and the accumulation of PrP
Sc particularly within
the CNS. The sites of PrP
Sc accumulation vary depending
on the combination of host and prion strain under inves-
tigation, for instance classical ovine scrapie, cervid CWD
and human vCJD display widespread distribution of
PrP
Sc within the CNS and lymphoreticular tissues (LRS)
[2-4] whereas for cattle BSE, atypical scrapie and human
CJD the accumulation of PrP
Sc within LRS is much more
restricted [5,6].
To date, studies investigating the shedding of the prion
agent have focussed on scrapie and CWD. There is accu-
mulating evidence for the excretion of prions within milk
[7,8], urine [9,10], saliva [10-12] and faeces [13]. Such
reports utilise methodologies that are exquisitely sensitive
in their detection of prion infectivity or PrP
Sc,n a m e l y
bioassay or amplification of PrP
Sc by serial protein misfold-
ing cyclic amplification (sPMCA). PMCA was pioneered by
Soto et al. [14] in a rodent model of scrapie and this is an
in vitro technique that amplifies trace amounts of PrP
Sc
within a test sample during iterative rounds of sonication
and incubation at 37°C. Importantly, this technique has
been adapted for the high level amplification of PrP
Sc from
natural sources of prion infection including ovine scrapie
[15], bovine BSE [16], human CJD [17] and cervid CWD
[18].
There is evidence from experimentally infected animals
that prions are excreted in faeces. Safar et al. [13] used a
rodent scrapie model to demonstrate the presence of prions
in faeces when measured by conformation-dependent
immunoassay (CDI) and transgenic mouse bioassay. Prions
were present in faeces from hamsters throughout disease
incubation. An analogous study in hamsters employed the
sPMCA amplification of prions in faecal extracts and
demonstrated the presence of prions during clinical disease
[19]. In addition, experimentally infected mule deer
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any medium, provided the original work is properly cited.excreted prion infectivity in faeces during preclinical and
clinical stages of CWD [20].
Here, we apply sPMCA to investigate the excretion of
prions within the faeces of naturally infected sheep,
both in the preclinical and clinical stages of disease
progression.
Materials and methods
Samples
Faecal samples were removed directly from the gut at post
mortem or from the rectum of live animals while avoiding
contamination with blood. Visible contamination with
blood was not observed in any of the samples. This
method of collection also minimised any contamination
from the environment. Samples were stored at -20°C until
assayed. Faeces were collected from sheep homozygous for
VRQ (codons 136, 154 and 171 respectively of the PRNP
gene) at 9 to 10 months of age and at clinical end-point
(mean survival time of 22 months of age). As negative
controls, faeces were collected from VRQ/VRQ unexposed
sheep from a VLA New Zealand derived flock. No consis-
tent differences in the consistency of the faeces were
observed between exposed and negative control sheep.
Faeces suspension preparation
Method 1 [Silicon dioxide (SiO2)]: After thawing, faecal
pellets were transferred to 50 mL disposable tubes for
homogenisation and diluted to three times the original
mass using phosphate buffered saline (PBS, 15 mM
KH2PO4,8 1m MN a 2HPO4,1 3 7m MN a C l ,a n d3m M
KCl) containing 2× miniprotease inhibitors (without
EDTA, Roche, Welwyn Garden City, UK). Each faecal
suspension was vortexed for 5 to 10 min until homoge-
neous and 0.5 mL aliquots of this 33% faecal homogenate
were transferred to a 15 mL falcon tube and stored at
-80°C until required.
Method 2 [Sodium Phosphotungstic acid (NaPTa)]:
After thawing the faecal samples were transferred to dis-
posable tubes for homogenisation and diluted 1:9 in
water containing protease inhibitors (Roche). The sam-
ples were then homogenised using the Prionics Prio-
GENISER™ (Prionics, Zurich, Switzerland) twice for 40 s
at maximum speed. Prions were then extracted from
faecal homogenates using NaPTa.
Extraction of prions
Method 1 [SiO2]: Faecal homogenates (0.5 mL of a 33%
w/v faecal homogenate) were diluted 1:1 in 2× phos-
phate buffer (pH 7) containing 1% deoxycholate (DOC)
and 1% NP40, then further diluted to 5 mL with 1× PBS
containing 0.5% DOC and 0.5% NP40. The faecal homo-
genates were then incubated for 1 h at room tempera-
ture (RT). Following centrifugation at 1500 g for 3 min
the supernatant was removed and the pellet discarded.
80 μLo fa2 0 %( w / v )S i O 2 suspension were added to
the 5 mL faecal supernatant and the sample rotated
gently for 2 h at RT. The samples were centrifuged at
700 g for 4 min and the supernatant discarded. The
SiO2 pellets were washed by gentle pipetting using 1 mL
0.1% SDS.
Method 2 [NaPTa]: Faecal homogenates (0.5 mL of a
10% w/v homogenate in deionised water containing pro-
tease inhibitors (mini-pill complete, Roche)) were trans-
ferred to homogenisation tubes and sodium dodecyl
sulphate (SDS) added to a final concentration of 1%. The
samples were then ribolysed (BioRad, Hemel Hempstead,
UK) three times for 45 s each and cooled between each
cycle. The samples were incubated at RT for 1 h rotating
gently. Homogenates were then centrifuged for 20 min at
4°C at 15 000 g and the supernatants transferred to a clean
tube. The pellets were discarded. The supernatant was
diluted 1:1 with PBS containing 4% N-Lauroylsarcosine
sodium salt (Sigma, Poole, UK) and treated with Benzo-
naze (1 unit/μL, Sigma) for 30 min at 50°C. Following
treatment, NaPTa was added to a final concentration of
0.57% and the sample incubated at 37°C rotating gently
for 30 min. Samples were centrifuged at 15 000 g for 15
min at 10°C and the supernatant discarded. Pellets were
frozen at -80°C. Upon analyses, pellets were resuspended
in 50 μL of PMCA buffer (PBS, additional 150 mM NaCl,
4 mM EDTA, pH8.0, 1.0% (v/v) Triton X-100 and
miniprotease inhibitor, Roche).
Amplification of prions
Method 1 [SiO2]: Faecal extracts derived from SiO2 pre-
cipitation were centrifuged at 16 000 g for 3 min. 10 μL
of each faecal extract supernatant (from the equivalent
of 8.3 mg wet weight of faeces) were mixed 1:9 with
normal ovine brain homogenate. The samples were then
subjected to 40 s cycles of sonication every 30 min incu-
bating at 37°C for 24 h (1 round), after which the ampli-
fied samples were diluted 1:2 with PMCA substrate in a
final volume of 100 μL and the sample subjected to
f u r t h e rr o u n d so fP M C A .T e nr o u n d so fa m p l i f i c a t i o n
were carried out. The amplification product was stored
at -20°C. Samples from sheep incubating scrapie as well
as from sheep not exposed to the scrapie agent were
analyzed concurrently within the same run on the same
sonicator. Each SiO2 extract was amplified within two
separate experiments. After 10 rounds of amplification
in the absence of PolyA no de novo synthesis was
observed. Amplification was not extended beyond 10
rounds.
Method 2 [NaPTA]: Faecal extracts derived from
NaPTa precipitation (8 μL; from the equivalent of 8 mg
wet weight of faeces) were mixed 1:9 with normal ovine
brain homogenate (obtained at post mortem from a
VRQ/VRQ sheep from the New Zealand-derived VLA
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buffer) supplemented with synthetic polyA RNA to a
final concentration 100 μg/mL. The samples were then
subjected to 40 s cycles of sonication every 30 min incu-
bating at 37°C for 24 h (1 round). The sonicated pro-
duct was then replenished 1:4 with fresh normal brain
homogenate and sonication repeated for a further 24 h.
This was repeated until four rounds were completed.
Using this PMCA protocol rounds were restricted to 4
because de novo synthesis was observed at 6 rounds or
more under PrP
Sc free conditions (data not shown). No
de novo synthesis was observed in the presence of
PolyA at round 4. The amplification products were
stored after all PMCA rounds at -20°C until tested for
PrP
Sc content.
Analysis of PrP
Sc
PMCA products were tested using the IDEXX HerdChek
antigen test for scrapie as directed by the manufacturers.
Positives were scored using the manufacturer’sc u t - o f f
values. Alternatively, PMCA samples were digested with
50 μg/mL proteinase K, 0.045% (w/v) SDS for 1 h at 37°C
before analysis by Western blotting using 12% (w/v)
NuPAGE pre-cast Bis-Tris gels as previously described
[21].
Statistical analysis
When comparing the percentage of positive sPMCA
reactions for different cohorts of samples, data were set
up as 2 × 2 contingency tables and Fisher’se x a c tt e s t
(one-tailed) was applied to derive p-values.
Results
Faeces were sampled directly from the transverse colon
of clinically-affected sheep at post mortem or from the
rectum of live sheep with preclinical scrapie. Prions were
extracted from faeces employing a mild detergent extrac-
tion (0.5% w/v DOC and NP40) followed by SiO2 precipi-
tation. Prions extracted using SiO2 were amplified over
10 rounds of sPMCA before attempted detection of PrP
Sc
by Western blot. This method was previously shown to
amplify prions from the saliva of sheep incubating scrapie
[11]. Here, when applied to the faeces from scrapie
infected animals, PrP
Sc was amplified from 6 of 29 ani-
mals: four animals with clinical disease and two animals
which were clinically normal at approximately the mid-
point of disease incubation (10 positive sPMCA reactions
from 58 analyses; Figure 1, Table 1). No prions were
amplified from faeces collected from sheep which had
not been exposed to the scrapie agent (10 animals, 60
analyses, Figure 1, Table 1). These data demonstrate that
prions were secreted in faeces from sheep incubating
natural scrapie (p = 0.001).
In order to estimate the levels of scrapie prions present
within faeces, the limit of detection of the methodology
was determined for the earliest sPMCA round that
amplified PrP
Sc from both preclinical and clinical faecal
samples. Using SiO2 extraction coupled with sPMCA
amplification of prions in the absence of polyA RNA,
seven rounds of sPMCA amplification yielded detectable
PrP
Sc for 4 of the samples, 3 taken from clinical animals
(0320/09, 0324/09, 0572/09) and one taken from an ani-
mal in the preclinical stage of disease (1305/09). A dilu-
tion series of a brain homogenate from an animal with
terminal scrapie was spiked into a faecal homogenate and
then extracted and amplified. Extraction followed by
amplification for 7 rounds of sPMCA detected PrP
Sc
down to 0.64 ng of brain material spiked into 167 mg wet
weight of faeces (data not shown).
To investigate further the shedding of prions in faeces,
a second method of extraction and amplification was
developed. This method used potentially more stringent
extraction conditions and enhanced sPMCA amplifica-
tion. Briefly, prions were eluted from faeces with 1% SDS
followed by NaPTa precipitation of prions and sPMCA
amplification employing polyA;-the presence of polyA
having been shown to increase the sensitivity of the
sPMCA amplification [15,22]. The presence of PrP
Sc was
demonstrated in the amplification product using the
IDEXX HerdChek antigen assay for scrapie (Table 1).
PrP
Sc was detected in the faeces of all 14 sheep which
were in the preclinical stages of scrapie and sampled at 9
to 10 months of age (19 positive sPMCA reactions from
22 analyses; Table 1). Of the sheep at clinical end-stage,
PrP
Sc was amplified from the faeces of 6 out of 15 sheep
(8 out of 27 analyses were positive). Analyses of animals
not exposed to the scrapie agent again demonstrated that
no prions could be detected (25 animals, 45 analyses;
Table 1 and data not shown). These data indicate that
scrapie prions are excreted in faeces in both preclinical
(p < 0.001) and clinical (p < 0.001) stages of the disease.
PrP
Sc was detected at the earliest following round 4 using
this method except in 1 sample (324/09) where PrP
Sc was
detected following round 3.
These data report for the first time the excretion of
prions in the faeces of naturally infected animals and
further support the role of the faecal-oral route as a
means of horizontal transmission in the field.
Discussion
The reported study demonstrates the presence of prions in
the faeces of sheep naturally infected with scrapie. Addi-
tionally, PrP
Sc was present in the faeces of sheep both in
the terminal stages of disease and when in the early precli-
nical phase, suggesting that prions are likely to be shed
into the environment throughout pathogenesis. These
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infected with CWD [20] where infectivity was observed in
faecal samples collected from the deer from nine months
after inoculation and maintained during the clinical phase
several months later. Together these data are fully consis-
tent with faeces being a source of environmental prion
contamination that contributes to transmission for both
scrapie and CWD.
Within the present study, two distinct methods were
applied to detect faecal PrP
Sc. Prions were detected less
frequently when employing mild detergent extraction,
SiO2 precipitation and a standard sPMCA amplification,
compared to when using SDS extraction, NaPTa preci-
pitation and sPMCA incorporating polyA. This may
indicate that the latter method has an improved sensitiv-
ity. The method based on mild extraction and non-
enhanced sPMCA detected prions more frequently in
clinical samples and in contrast the method based on
SDS extraction and polyA-enhanced amplification
detected prions more frequently in preclinical samples.
This suggests that preclinical animals may be more
likely to secrete prions compared to animals with clini-
cal disease, but that the levels of prion present within
faeces is higher in the clinical animals. With the mild
extraction conditions amplification of prions was
observed at earlier rounds in samples from clinical com-
pared to preclinical animals, supporting the proposition
that prions are at higher levels in faeces during clinical
disease.
Several sources of prions in faeces could be postulated
including environmental ingestion and swallowing of
infected saliva [11]. However, the most likely source is
shedding from the gut-associated lymphoid tissue. Early
and rapid accumulation of PrP
Sc in the Peyer’s patches is
consistent with the detection of prions in faeces during
the preclinical phase. In sheep with a VRQ/VRQ PRNP
genotype this accumulation commences at around 2-3
months of age. Ruminants have specialised Peyer’s
patches that are continuous throughout the length of the
ileum amounting to approximately 100 000 follicles and
all of these could potentially be infected and shedding
prions into the lumen. However the number of follicles
diminishes at around 12-15 months of age thus reducing
the potential for shedding at this site in older sheep such
as those with clinical disease in the present study. Addi-
tionally, the recto-anal mucosa associated lymphoid tis-
s u em a ya l s op l a yar o l ei nc o n t r i b u t i n gt ot h el e v e l so f
PrP
Sc found in the faeces; in the present study this route
would not contribute to prion in the samples from clini-
cal sheep due to direct sampling from the gut. These fac-
tors would be expected to result in lower prion levels
and/or a lower frequency of prion excretion within the
clinical faecal samples. However, this is not supported by
the presented data indicating that levels of prion
Figure 1 Prion excretion in faeces of healthy and clinical scrapie infected sheep. Prions extracted from 8.3 mg of faeces were used as seed
for Method 1 [10 rounds of sPMCA]. After 4 to 10 rounds of sPMCA (as indicated), products were digested with proteinase K and 10 μL applied
to Western blots. PrP was detected with monoclonal antibodies SHA31 and P4; molecular weight markers are shown (M1, 20 and 30 kDa; M2, 19
and 28 kDa). Sheep were either in the preclinical (lanes 1 and 2 for animals 1236/09 and 1305/09 respectively) or clinical stages of disease
progression (lanes 3-6 for animals 0320/09, 0324/09, 0470/09 and 0572/09 respectively) or were unexposed to the scrapie agent (lanes 7-16 for
animals R185, R223, R233, R234, R297, R303, R328, R382, R413 and R421 respectively). Two analyses were carried out for each sample and
representative analyses are shown. Cerebellum (2.5 μL of a 10% w/v homogenate) from a terminally affected sheep was analysed on each blot
as a PrP
Sc control (C).
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Sc from sheep faeces
Origin of faecal sample Animal
ID
number positive/total number of analyses
Method 1
a
number of positive/total number of analyses
Method 2
b
R382 0/6 0/2
R328 0/6 0/2
R234 0/6 0/2
R413 0/6 0/2
R421 0/6 0/2
Unexposed sheep R185 0/6 0/1
R223 0/6 0/1
R233 0/6 0/1
R297 0/6 0/1
R303 0/6 0/1
Total 0/60 0/15
c
1203/09 0/2 2/2 (4,4)
1236/09 1/2 (9)
d 1/2 (4)
1252/09 0/2 2/2 (4,4)
1271/09 0/2 2/2 (4,4)
1284/09 0/2 2/2 (4,4)
1292/09 0/2 2/2 (4,4)
Preclinical exposed sheep age 9-10
months
1298/09 0/2 1/2 (4)
1305/09 2/2 (7,10) 1/2 (4)
1227/09 0/2 1/1 (4)
1279/09 0/2 1/1 (4)
1286/09 0/2 1/1 (4)
1296/09 0/2 1/1 (4)
1299/09 0/2 1/1 (4)
1307/09 0/2 1/1 (4)
Total 3/28 19/22
317/09 0/2 0/2
319/09 0/2 1/2 (4)
320/09 2/2 (6,6) 1/2 (4)
324/09 1/2 (6) 2/2 (3,4)
421/09 0/2 0/2
352/09 0/2 0/2
353/09 0/2 0/2
Sheep with clinical scrapie 354/09 0/2 0/2
359/09 0/2 1/2 (4)
382/09 0/2 0/2
457/09 0/2 0/2
470/09 2/2 (8,9) 2/2 (4,4)
606/09 0/2 0/1
608/09 0/2 1/1 (4)
572/09 2/2 (7,9) 0/1
Total 7/30 8/27
aMethod 1: Prion was extracted in NP40 and DOC, precipitated with SiO2 and amplified by sPMCA for 10 rounds.
bMethod 2: Prions were extracted in SDS, NaPTa precipitated and amplified by sPMCA in the presence of polyA for 4 rounds.
cFaeces from a further 15 animals was analysed in duplicate by this method and no prions were detected (data not shown).
dThe sPMCA round at which the sample first became positive is indicated in parenthesis.
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RAMALT or the ileal Peyer’s patches.
Not all prion diseases result in infection of the gut-
associated lymphoid tissue. The low levels of prion
infection in the gut of cattle with natural BSE [23] could
explain the apparent, fortuitous failure of lateral spread
of BSE within herds.
Here, with the estimated levels of prion shed within the
faeces combined with an estimated ovine faecal output of
67 kg/month [24] it could be speculated that between
9 months and 22 months of age sheep could excrete prions
equivalent to the potentially infectious load within approxi-
mately 3.3 mg of clinically infected brain. Tamguney et al.
[20] used bioassay to estimate the levels of infectivity in
faeces from experimentally-infected CWD deer; over a
10 month period these levels were estimated to approach
that present within a clinically infected whole brain. These
levels are much higher than those found in the present
study with scrapie infected sheep; however, this could
reflect differences between the prion strains and host spe-
cies under investigation or be due to differences in the
prion detection methodologies employed.
Previous studies have indicated that risk factors for
horizontal transmission in the field involve contact dur-
ing the postnatal period [25-27]. However, exposure to
pasture that has been grazed by infected sheep is suffi-
cient to transmit disease even in the absence of lambing
[25,28]. The findings of the present study would suggest
that prions in faeces will contribute to this contamination
and support the role of the faecal-oral route as a means
of horizontal transmission. Strategies for the control of
scrapie will need to take this into account particularly for
goats where successful elimination is still reliant on
depopulation, disinfection and restocking.
In North America, the presence of prions in secreta and
excreta of deer and the resultant contamination of the
environment is likely to have contributed to the spread of
CWD and this is likely to progress unabated given the esti-
mation of the amount of prions contained within cervine
faeces [20]. Therefore environmental contamination of
pasture remains a serious impediment to future eradica-
tion of prion disease in both Europe and in North
America.
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